Platelet activating antagonists
US5149704A · kind A · utility
2Cited by
3References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 3, 1991 |
| Grant date | Sep 22, 1992 |
| Priority date | — |
| Expiry date | May 3, 2011 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Benzoylphenyl derivatives of 2-(3-pyridinyl)-3-alkyl-4-thiazolidinecarboxamide, 2-(3-pyridinyl)-thiazolid-4-ylacetamide, 2-(3-pyridinyl)-4-dithiolanecarboxamide or 2-(3-pyridinyl)dithiolan-4-yl]urea-group are potent inhibitors of PAF and are useful in the treatment of PAF-related disorders including anaphylactic shock, respiratory distress syndrome, acute inflammation, delayed cellular immunity, parturtition, fetal lung maturation, and cellular differentiation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.